SYRE
Spyre Therapeutics, Inc.
Key figures
| Metric | Latest |
|---|---|
| Revenue | $02025 |
| Operating income | −$250M |
| Net income | −$264M |
| EPS | $13.762023 |
| Free cash flow | −$157M2024 |
Spyre Therapeutics, Inc.
| Metric | Latest |
|---|---|
| Revenue | $02025 |
| Operating income | −$250M |
| Net income | −$264M |
| EPS | $13.762023 |
| Free cash flow | −$157M2024 |